Case Studies

Explore these handpicked case studies to gain a comprehensive understanding of the extensive projects we undertake, the high level of expertise we deliver, and our demonstrated history of successful partnerships.

February 10, 2026

Designing an Early Access Pathway for a CNS Therapy Using Real-World and Claims Insights

Background: A mid-stage biopharma company was advancing a novel CNS…

January 27, 2026

Building a Global Patient Funnel to Predict Uptake for a Gene Therapy Across 15 Countries

Context: A global biotech developing an ex-vivo gene therapy for…

January 16, 2026

How Thelansis helped a Pharma company mitigate LOE impact through Forecast Modelling & Market Analytics

Background: In 2024, a mid-size specialty pharma company approached Thelansis…

December 4, 2025

Building a Global Price Strategy: How Thelansis Helped a Biopharma Set the Right Launch Price Across 15 Markets

Background: A biopharma company was preparing to launch a first-in-class…

December 4, 2025

Optimizing Biotech Investment Strategy in an Uncertain Market Landscape

Introduction: A US-based mid-size biotech firm was preparing for its…

December 2, 2025

Strengthening Global Market Access Readiness Through Early Payer & HTA Planning

Introduction: A global biopharma company preparing to advance towards asset…

November 28, 2025

How Thelansis Supported a Mid-Sized Biopharma Company in Out-Licensing Their Novel IPF Asset

Introduction: During 2024, a mid-sized biopharma company from the European…

October 31, 2025

Optimizing Multi-channel Distribution and Inventory Agility in Pharmaceutical Industry through Demand-Based Forecasting

Introduction: The pharma ecosystem is quite complex, wherein companies operate…

October 30, 2025

Smart Pipeline Decisions: AI-Powered Indication Prioritization for Oncology TA

Background: In the current scenario, the competitive landscape of oncology…

October 30, 2025

Mapping the Future: Identifying High-value Therapy Area Strategy for Emerging Markets

Background: In an evolving global disease landscape, identifying the right…

October 30, 2025

The Analogue Advantage: A Smarter Way to derive the market uptake and New Product revenue Forecast

Background: Launching a new therapy in the oncology space is…

October 28, 2025

From Evidence to Impact: How Thelansis Accelerated a Rare Disease Submission

Introduction: In recent years, the healthcare landscape has evolved toward…